Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Microvascular Research|April 28, 2010
Digital laser doppler flowmetry may discriminate "limited" from "diffuse" systemic sclerosisVito Grattagliano, Florenzo Iannone, Emanuela Praino, et al.
Clinical Rheumatology|January 20, 2020
Digital ulcer debridement in systemic sclerosis: a systematic literature reviewMichael Hughes, Begonya Alcacer-Pitarch, Ana Maria Gheorghiu, et al.
Journal of Clinical Medicine|August 22, 2019
Systemic Sclerosis Serum Steers the Differentiation of Adipose-Derived Stem Cells Toward Profibrotic Myofibroblasts: Pathophysiologic ImplicationsMirko Manetti, Eloisa Romano, Irene Rosa, et al.
European Journal of Clinical Investigation|November 27, 2022
Prevalence and management of tuberculosis infection in Apulian rheumatologic patients treated with biologics: An observational cohort 10-year study from the BIOPURE registryMarco Fornaro, Stefano Stano, Delia Goletti, et al.
Clinical and Experimental Rheumatology|April 6, 2013
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values changeMarco Sebastiani, Andreina Manfredi, Andrea Lo Monaco, et al.
Diagnostics (Basel, Switzerland)|February 24, 2024
Orofacial Manifestation of Systemic Sclerosis: A Cross-Sectional Study and Future Prospects of Oral CapillaroscopyAnna Antonacci, Emanuela Praino, Antonia Abbinante, et al.
Clinical Hemorheology and Microcirculation|January 28, 2014
Prediction risk chart for scleroderma digital ulcers: a composite predictive model based on capillaroscopic, demographic and clinico-serological parametersAndreina Manfredi, Marco Sebastiani, Valeria Carraro, et al.
Clinical and Experimental Rheumatology|September 17, 2020
Psychosocial burden in young patients with primary anti-phospholipid syndrome: an Italian nationwide survey (The AQUEOUS study)Cecilia Beatrice Chighizola, Francesca Crisafulli, Ariela Hoxha, et al.
Clinical and Experimental Rheumatology|July 25, 2024
Effectiveness of ixekizumab over 24 months in different clinical scenarios in psoriatic arthritis: results from the Gruppo Italiano Studio Early Arthritis multicentric prospective registryMaria Sole Chimenti, Mauro Fatica, Marco Fornaro, et al.
Therapeutic Advances in Musculoskeletal Disease|February 3, 2025
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA RegistryGiuseppe Lopalco, Maria Morrone, Fabiola Atzeni, et al.
Pageof 3